Sanofi inaugurated its Shanghai foreign R&D innovation center and signed a
collaboration with Fudan University-affiliated Huashan Hospital to establish a
Sanofi–Huashan "Excellence Translational Center". The center will be Sanofi’s
largest translational medicine facility in China, consolidating global R&D
capacity to advance immunology, chronic disease, oncology and rare-disease drug
development. In 2025 Sanofi posted EUR 46.7 bln in revenue; China is its
second-largest market globally.
